EN DE
STOCK COMPARISON

Boai NKY Pharmaceuticals vs Linde plc Ordinary Shares: Fair Value & Quality

Both stocks run through our valuation models. Here is how Boai NKY Pharmaceuticals (300109) and Linde plc Ordinary Shares (LIN) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Boai NKY Pharmaceuticals as the less overvalued of the two: Boai NKY Pharmaceuticals trades at ¥13.06 versus a fair value of ¥6.69 (-49%), while Linde plc Ordinary Shares trades at $490 versus $222 (-55%).
Boai NKY Pharmaceuticals
300109.SHE · CNY · Materials
-49%
upside to fair value
overvalued
Price¥13.06
Fair Value¥6.69
Quality58/100
Linde plc Ordinary Shares
LIN · USD · Materials
-55%
upside to fair value
overvalued
Price$490
Fair Value$222
Quality70/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Boai NKY PharmaceuticalsLinde plc Ordinary Shares
Valuation
50.1×P/E (TTM)34.1×
7.09×P/S (TTM)6.95×
2.30×P/B6.30×
20.9×EV/EBITDA18.9×
—PEG2.18×
1.1%Dividend yield1.2%
¥0.20Dividend per share$6.10
Profitability
15%Net margin20%
23%Operating margin28%
5%Return on equity18%
4%Return on assets7%
Growth
5%Revenue growth (YoY)8%
-7.4%Avg. growth/yr (3Y)0.6%
3.8%Avg. growth/yr (5Y)4.5%
Balance & size
0.04×Debt / equity0.54×
$1BMarket cap$241B
expensiveGrowth qualityhealthy

Linde plc Ordinary Shares leads: 2 to 11 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Boai NKY Pharmaceuticalsof which business quality 58 · market factors 28 Linde plc Ordinary Sharesof which business quality 66 · market factors 61
ProfitabilityMargins and returns on capital today
34
51
Quality GrowthAre margins and returns improving?
24
51
CashflowEarnings quality: real cash, not paper profit
58
64
Fin. StrengthBalance sheet, leverage, solvency risk
90
69
InvestmentDisciplined investing over empire-building
51
70
Low VolatilityCalm price path (market factor)
67
87
MomentumPrice trend over the last 3–12 months (market factor)
16
48
52W MomentumDistance to the 52-week high (market factor)
5
52
Net IssuanceBuybacks instead of dilution
90
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Boai NKY Pharmaceuticals

DCF Models¥7.68
Earnings-Based¥5.97
Dividend Discount¥4.37
Multiples¥6.69
Asset-Based¥5.11
Growth DCF¥6.32
Economic Profit¥6.15
Growth Earnings¥7.45

25 of 26 models see the stock below the current price.

Linde plc Ordinary Shares

DCF Models$211
Earnings-Based$132
Dividend Discount$116
Multiples$239
Asset-Based$55.42
Growth DCF$155
Economic Profit$156
Growth Earnings$204

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Boai NKY Pharmaceuticals
Bear ¥5.01Fair Value ¥6.69Bull ¥8.36
¥13.06 = current price (white tick)
Linde plc Ordinary Shares
Bear $121Fair Value $222Bull $291
$490 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Boai NKY Pharmaceuticals · Materials

Quality score58 · above median
Fair value upside-49% · below median

Linde plc Ordinary Shares · Materials

Quality score70 · Top 25%
Fair value upside-55% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Boai NKY Pharmaceuticals as the less overvalued of the two: Boai NKY Pharmaceuticals trades at ¥13.06 versus a fair value of ¥6.69 (-49%), while Linde plc Ordinary Shares trades at $490 versus $222 (-55%).

Linde plc Ordinary Shares has the higher quality score (70/100).

See the full analysis →
Boai NKY Pharmaceuticals · Linde plc Ordinary Shares

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Boai NKY Pharmaceuticals

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Linde plc Ordinary Shares

Amazon.com vs PDD HoldingsAmazon.com vs Sony GroupMeta Platforms vs Verizon CommunicationsMeta Platforms vs At&t
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.